it is not a generic and is not the same as Ozempic
Keep personal dosing changes with a licensed prescriber rather than a generic chart
Market forces, regulatory pressure, new-to-market medications, and shifting patient and payor expectations continue to reshape how employers, consultants, and PBMs work together to manage prescription benefits
Daniel Santana Vargas is a speaker for Grnenthal
The biotech firm Metsera, which is developing a once-monthly GLP-1 injection, became the object of a bidding war between Pfizer and Novo Nordisk, with Pfizer emerging as the winner
Despite this brief duration, GLP-1 exerts significant physiological effects on glucose homeostasis, appetite regulation, and gastric emptying